Related Experiment Video
Updated: Sep 19, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Epidemiologic trends for pediatric Hodgkin and non-Hodgkin lymphomas: a U.S. population-based study
Weishi Cheng1, Xu Sun2, Shijie Yang3
1Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Insights
Pediatric lymphoma incidence increased after 2003, with rising prevalence. In contrast, adult lymphoma incidence decreased, and mortality rates declined significantly over four decades, showing a positive trend in pediatric cancer outcomes.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Pediatric Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) differ from adult forms and are less common.
- Understanding trends in pediatric and adult lymphoma incidence, prevalence, and mortality is crucial for public health strategies.
Purpose of the Study:
- To analyze and compare the epidemiological trends of pediatric and adult lymphoma from 1975 to 2018.
- To assess changes in incidence, prevalence, and mortality rates for both pediatric and adult lymphoma populations.
Main Methods:
- Utilized data from the Surveillance, Epidemiology, and End Results (SEER) database (1975-2018).
- Analyzed age-adjusted incidence, prevalence, and mortality rates for pediatric (7,871 cases) and adult (226,211 cases) lymphoma.
- Calculated annual percentage change (APC) to identify trends over specific periods.
Main Results:
- Pediatric lymphoma incidence showed no significant change from 1975-2002 but increased after 2003 (APC = +1.31).
- Pediatric lymphoma prevalence rates increased, with 5-year rates rising and 20-year rates showing a consistent upward trend.
- Adult lymphoma incidence decreased in recent years, while mortality rates, after an initial rise, showed a significant decline after 1994 (APC = -0.49).
- Pediatric lymphoma mortality rates consistently decreased over four decades (APC = -3.12).
Conclusions:
- Pediatric lymphoma incidence has shown an increasing trend in recent years, accompanied by rising prevalence.
- Adult lymphoma trends show a decrease in incidence and a significant decline in mortality, indicating improved outcomes.
- The consistent decrease in pediatric lymphoma mortality over four decades suggests positive developments in treatment or care, despite increasing incidence.
Abstract:
Pediatric Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are distinct from adult forms and occur less frequently. We identified 7,871 children and 226,211 adults with lymphoma from the Surveillance, Epidemiology, and End Results database from 1975 to 2018. The age-adjusted incidence rate for pediatric lymphoma was 24.5 per million persons (95% CI: 24.0-25.1), comprising 13.0 per million (95% CI: 12.6-13.4) for HL and 11.5 per million (95% CI: 11.1-11.9) for NHL. In comparison to adult lymphoma, pediatric lymphoma showed no significant changes in incidence from 1975 to 2002 (annual percentage change, APC = -0.12 ± 0.19, P = 0.53), but displayed an observable increase after 2003 (APC = + 1.31 ± 0.45, P = 0.006). Among pediatric cases, the 5-year limited-duration prevalence rate increased from 0.00691% in 1996 to > 0.009% in recent years, and the 20-year rate rose from 0.0109% in 1996 to 0.0148% in 2018. In alignment with the observed decrease in incidence over the recent decade, the prevalence of adult lymphoma exhibited a more gradual growth post-2007. Among adult patients, the age-adjusted mortality rate demonstrated an initial increase in the periods 1975-1977 (APC = + 41.06 ± 6.23, P < 0.001), 1977-1980 (APC = + 9.83 ± 4.27, P = 0.036), 1980-1989 (APC = + 5.24 ± 0.36, P < 0.001), and 1989-1994 (APC = + 2.27 ± 0.86, P = 0.014), followed by a subsequent decrease after 1994 (APC= -0.49 ± 0.05, P < 0.001). In contrast, the mortality rates of pediatric lymphoma exhibited a consistent decrease over the past four decades (1975-2018: APC= -3.12 ± 0.29, P < 0.001), resulting in an overall age-adjusted mortality rate of 2.92 (95% CI: 2.73-3.11).
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Statistical Methods for Analyzing Epidemiological Data
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

